Big Players' Recent Trades in NVO Options
Portfolio Pulse from Benzinga Insights
Significant options activity has been detected in Novo Nordisk (NYSE:NVO), with a bullish sentiment prevailing among big-money investors. Benzinga's options scanner revealed 15 unusual options trades, with a split of 73% bullish and 26% bearish. The focus is on a price range between $87.5 and $105.0 for the stock. The largest trades were bullish CALL options with expiration dates in December 2023 and January 2025. Novo Nordisk, a leader in diabetes care products, is currently trading at $99.54 with neutral RSI readings and its earnings release expected in 79 days.
November 13, 2023 | 2:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novo Nordisk has seen significant options trading with a bullish bias, indicating potential positive movement in the stock price in the short term.
The large volume of bullish options trades suggests that investors with significant capital are expecting a positive price movement for NVO. The specific focus on CALL options with strike prices within the $87.5 to $105.0 range indicates a targeted expectation for stock price increase. The current neutral RSI and the anticipation of earnings release in 79 days may also contribute to increased investor interest and potential stock volatility.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100